Overview

Combined Pharmacotherapies for Alcoholism

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This study would like to test whether the combination of ondansetron and naltrexone will be superior to either medication alone or placebo in the treatment of alcohol dependence.
Phase:
Phase 3
Details
Lead Sponsor:
Bankole Johnson
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Treatments:
Naltrexone
Ondansetron